Thursday, September 18, 2014 Last update: 12:33 AM
FreshNews.com - All Company Technology News Since 1996

Nora Therapeutics to Present at the 21st Annual Future Leaders in the Biotech Industry Conference

Companies mentioned in this article: Nora Therapeutics

PALO ALTO, Calif., March 21, 2014 /PRNewswire/ -- Nora Therapeutics, a biotechnology company focused on developing therapeutics to address unmet needs in reproductive medicine, announced today that CEO Jeffrey K. Tong, Ph.D., is scheduled to present at the 21(st) Annual Future Leaders in the Biotech Industry Conference at the Millennium Broadway Hotel in New York City on Friday, March 28, 2014 at 3:20 p.m. EDT.

About Nora Therapeutics, Inc.
Nora Therapeutics is a privately-held biotechnology company focused on developing therapeutics to address IVF failure and recurrent pregnancy loss, two reproductive conditions with significant unmet need. Nora's lead compound, NT100, is a novel biologic agent similar to a naturally occurring protein in the female reproductive tract and may better enable embryo implantation and pregnancy maintenance by optimizing maternal-fetal immune tolerance. For more information, please visit our website at www.noratherapeutics.com.

SOURCE Nora Therapeutics